For example, overexpression of EFEMP1 eliminated tumor development and suppressed angiogenesis and VEGFA expression in hepatocellular carcinoma, gastric and prostate cancers, and glioblastoma [84,85], while the converse was true with ovarian and breast cancers [86]. Here, VEGFA is linked to hepatocellular carcinoma.